Menu

Mutant Mosquitoes Deployed to Stop Zika, Dengue

A Brazilian town will ramp up the release of insects engineered to shrink mosquito populations.

Jan 19, 2016
Kerry Grens

WIKIMEDIA, EMIL AUGUST GOELDIOxitec, a company that breeds genetically modified (GM) mosquitoes whose offspring die young, is launching a facility in Piracicaba, Brazil, to combat viral infections transmitted by Aedes aegypti mosquitoes. Already, Oxitec had been releasing its mosquitoes in a small region of Piracicaba; the program will now expand to the city center.

“This will bring to the city a new Oxitec factory to meet demand for years to come and help protect the public’s health with this clean and innovative technology,” Mayor Gabriel Ferrato said in a press release.

Oxitec’s program in Piracicaba began in April 2015, and, according to the press release, wild mosquito larvae numbers dropped 82 percent by the end of the year. The mosquitoes are genetically modified so that when mated with wild-type mosquitoes produce larvae that don’t make it to adulthood.

Thomas Scott, who studies vector-borne diseases at the University of California, Davis, said the results from field trials are encouraging. “It will be helpful if future trials can demonstrate disease reduction, determine that the strategy can be scaled-up to modern mega-cities with millions of people, establish sustainability of disease reduction, verify cost effectiveness, and lead to discussion about how this approach can be integrated with other control methods that already exist or are currently in development,” Scott, who has collaborated with Oxitec, said in a statement emailed to reporters (via Genetic Expert News Service).

June 2019

Living with Bacteria

Can pathogens be converted to commensals?

Marketplace

Sponsored Product Updates

Gyros Protein Technologies introduces Gyrolab E. coli HCP Kit for automated impurity analysis of biotherapeutics
Gyros Protein Technologies introduces Gyrolab E. coli HCP Kit for automated impurity analysis of biotherapeutics
Ready-to-use immunoassay kit increases analytical output and productivity in bioprocess workflows. Kit developed as part of licensing and supply agreement with Cygnus Technologies
IDT launches ultra-high performance CRISPR Cas12a enzyme
IDT launches ultra-high performance CRISPR Cas12a enzyme
IDT’s new CRISPR Cas12a (Cpf1) Ultra enzyme can target new sites within the genome and with greater efficiency
Implen Launches New NanoPhotometer N120: The High Throughput Champion!
Implen Launches New NanoPhotometer N120: The High Throughput Champion!
Implen GmbH is excited to announce the release of the NanoPhotometer® N120, an absorbance based UV/VIS Multi Channel Spectrophotometer.
StemExpress Announces Release of New Frozen Leukopak® to Advance Research
StemExpress Announces Release of New Frozen Leukopak® to Advance Research
To continue to provide new products and services to further advance medical research around the world, today, StemExpress announced the release of their Frozen Leukopak®.